Ask AI

Expert Analysis: Clinical Advances Journal Club on Emerging TROP-2 and TIGIT Therapies in Lung Cancer From ESMO 2025

Gain expert insights into the most recent clinical advances in investigational agents targeting TROP-2 and TIGIT in lung cancer to guide treatment selection and sequencing through a podcast, certified text module, expert-authored ClinicalThought commentary, and downloadable slides.

Share

Program Content

Activities

TROP2 TIGIT for NSCLC
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.